Ravulizumab
Ravulizumab (ALXN1210) is a humanized monoclonal antibody that specifically binds to human complement protein C5 with high affinity, targeting complement factor 5 to block complement activation. It can be used for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis.
Product Specifications
CAS Number
1803171-55-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Complement System
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
26021001 1250 PCS
0.2mL 8-Strip PCR Tube, White, with Flat Cap, 125 Strips with Caps*10bags/Carton
Sign In for Pricing
View Details 
FP-239-1 1 Vial 100 μL (10-20 T)
Chromosome 12/D13S25 gene deletion probe reagent (D13S25/CEP12)
Sign In for Pricing
View Details 312659-01 50 µL
CYP2J2 (Cytochrome P450 2J2, CPJ2, Arachidonic acid epoxygenase, CYPIIJ2)
Sign In for Pricing
View Details 
312659-02 100 µL
CYP2J2 (Cytochrome P450 2J2, CPJ2, Arachidonic acid epoxygenase, CYPIIJ2)
Sign In for Pricing
View Details